Core Viewpoint - Kangyuan Pharmaceutical's unique product, Heat Toxicity Ning Injection, has shown significant efficacy in treating viral infections, including dengue fever and respiratory infections, and is included in the national medical insurance catalog [1] Group 1: Product Information - Heat Toxicity Ning Injection received its new drug certificate in 2005 and is indicated for clearing heat, dispelling wind, and detoxifying [1] - The injection is used for symptoms caused by external wind-heat, such as fever, cough, and upper respiratory infections [1] Group 2: Clinical Research and Efficacy - Completed clinical studies for influenza, hand-foot-mouth disease, and COVID-19 indicate that Heat Toxicity Ning Injection can rapidly alleviate symptoms of viral infections, particularly high fever [1] - The injection has a high overall effective rate and can regulate inflammatory factors, effectively reducing inflammation and improving treatment outcomes [1] - Research on dengue fever shows that the injection significantly shortens fever relief time and improves the normalization rates of white blood cells and platelets [1] Group 3: Guidelines and Ongoing Research - Heat Toxicity Ning Injection is recommended in multiple guidelines, including the "Dengue Fever Diagnosis and Treatment Plan (2024 Edition)" [1] - The company is currently conducting clinical research in Guangdong to evaluate the efficacy of Heat Toxicity Ning Injection for treating Chikungunya fever [1]